Flora Growth (FLGC) vs. Its Rivals Head-To-Head Survey

Flora Growth (NASDAQ:FLGC) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Flora Growth to similar businesses based on the strength of its profitability, risk, valuation, analyst recommendations, institutional ownership, dividends and earnings.

Risk and Volatility

Flora Growth has a beta of 1.9, indicating that its share price is 90% more volatile than the S&P 500. Comparatively, Flora Growth’s competitors have a beta of 2.56, indicating that their average share price is 156% more volatile than the S&P 500.

Earnings and Valuation

This table compares Flora Growth and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Flora Growth	$57.61 million	-$15.91 million	-0.09
Flora Growth Competitors	$1.88 billion	$138.21 million	11.13

Flora Growth’s competitors have higher revenue and earnings than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Flora Growth and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Flora Growth Competitors	-278.38%	-150.31%	-21.96%

Institutional and Insider Ownership

36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 2.3% of Flora Growth shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings for Flora Growth and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1	0	0	0	1.00
Flora Growth Competitors	4242	10457	18169	819	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.72%. Given Flora Growth’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Flora Growth has less favorable growth aspects than its competitors.

Summary

Flora Growth competitors beat Flora Growth on 11 of the 13 factors compared.

About Flora Growth

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.